Loading…
Reported covered position: LA to Senator Pat Roberts 2006-2010
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNITY WELLNESS LLC (D/B/A MUSCULAR THERAPY LLC / SUMMIT WELLNESS OF TEXAS LLC) via BALLARD PARTNERS
2026 · third_quarter · Q3
Education regarding benefits of therapeutic massage therapy for veterans.
SHIONOGI, INC. via BALLARD PARTNERS
2026 · third_quarter · Q3
Source: Senate LDA
| HELFIE MANAGEMENT PTY LTD |
| 4 |
| 2026 |
| MADRIGAL PHARMACEUTICALS, INC. | 4 | 2025–2026 |
| PRESCIENT MEDICINE HOLDINGS, INC. | 4 | 2025 |
| RIO BIOPHARMACEUTICALS, INC. | 4 | 2025 |
| SOLUTIONS GROUP SERVICES, LLC | 4 | 2026 |
| SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. | 4 | 2026 |
| CAN COMMUNITY HEALTH | 3 | 2025 |
| KLAL YISROEL INC | 3 | 2025–2026 |
| MERCK SHARP & DOHME LLC | 3 | 2025 |
| SHIONOGI, INC. | 3 | 2026 |
| UNIVFY INC. | 3 | 2025 |
| 23ANDME RESEARCH INSTITUTE | 2 | 2026 |
| ARMR SCIENCES INC. | 2 | 2026 |
| SIGNATURE PERFORMANCE, INC. | 2 | 2026 |
| UNITY WELLNESS LLC (D/B/A MUSCULAR THERAPY LLC / SUMMIT WELLNESS OF TEXAS LLC) | 2 | 2026 |
| NOVO NORDISK, INC. | 1 | 2026 |
| OCEANSOUND PARTNERS | 1 | 2026 |
| PRAXIS PRECISION MEDICINES, INC. | 1 | 2026 |
| UPTODATE, INC. | 1 | 2025 |
Advocacy regarding biosecurity issues and treatments for rare disease.
Filing targets: Executive Office of the President (EOP), Natl Economic Council (NEC), White House Office
SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. via BALLARD PARTNERS
2026 · third_quarter · Q3
Medicare coverage and reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLUTIONS GROUP SERVICES, LLC via BALLARD PARTNERS
2026 · third_quarter · Q3
Medicare coverage and reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via BALLARD PARTNERS
2026 · third_quarter · Q3
Guidance regarding pharmaceutical regulations.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
MADRIGAL PHARMACEUTICALS, INC. via BALLARD PARTNERS
2026 · third_quarter · Q3
Advocacy related to prescription drug access and pricing.
HELFIE MANAGEMENT PTY LTD via BALLARD PARTNERS
2026 · third_quarter · Q3
Rural healthcare access and technology and the VA.
Rural healthcare access and technology and the VA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via BALLARD PARTNERS
2026 · third_quarter · Q3
Advocacy regarding IVF access and tariffs.
GENETIX BIOTHERAPEUTICS INC. via BALLARD PARTNERS
2026 · second_quarter · 2T
Advocacy regarding an FDA issue.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERIPRO HEALTH LLC via BALLARD PARTNERS
2026 · third_quarter · Q3
Medicare coverage and reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via BALLARD PARTNERS
2026 · third_quarter · Q3
Medicare Part D Coverage.
23ANDME RESEARCH INSTITUTE via BALLARD PARTNERS
2026 · third_quarter · Q3
Government grants, FDA classification, and NIH genomics policy.
Filing targets: Health & Human Services, Dept of (HHS), White House Office
UNITY WELLNESS LLC (D/B/A MUSCULAR THERAPY LLC / SUMMIT WELLNESS OF TEXAS LLC) via BALLARD PARTNERS
2026 · third_quarter · RR
Education regarding benefits of therapeutic massage therapy for veterans.
PRAXIS PRECISION MEDICINES, INC. via BALLARD PARTNERS
2026 · third_quarter · RR
Engagement and strategy for the FDA and HHS related to product pipeline.
ARMR SCIENCES INC. via BALLARD PARTNERS
2026 · second_quarter · 2T
Emergency use authorization.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), SENATE
2026 · second_quarter · 2T
Civic engagement services for government requirements.
SHIONOGI, INC. via BALLARD PARTNERS
2026 · second_quarter · Q2
Advocacy regarding biosecurity issues and treatments for rare disease.
SIGNATURE PERFORMANCE, INC. via BALLARD PARTNERS
2026 · second_quarter · Q2
Introduce Signature Performance and its capability to assist the VA and DoD in third party collections. With the use of advanced technology and data analytics, the federal government can become more effective in it's revenue collection system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. via BALLARD PARTNERS
2026 · second_quarter · Q2
Medicare coverage and reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLUTIONS GROUP SERVICES, LLC via BALLARD PARTNERS
2026 · second_quarter · Q2
Medicare coverage and reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MADRIGAL PHARMACEUTICALS, INC. via BALLARD PARTNERS
2026 · second_quarter · Q2
Advocacy related to prescription drug access and pricing.
HELFIE MANAGEMENT PTY LTD via BALLARD PARTNERS
2026 · second_quarter · Q2
Rural healthcare access and technology and the VA.
Rural healthcare access and technology and the VA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENETIX BIOTHERAPEUTICS INC. via BALLARD PARTNERS
2026 · second_quarter · Q2
Advocacy regarding an FDA issue.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via BALLARD PARTNERS
2026 · second_quarter · Q2
Advocacy regarding IVF access and tariffs.
Filing targets: Executive Office of the President (EOP), White House Office
AMERIPRO HEALTH LLC via BALLARD PARTNERS
2026 · second_quarter · Q2
Medicare coverage and reimbursement for ambulance services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALKERMES, INC. via BALLARD PARTNERS
2026 · second_quarter · Q2
Medicare Part D Coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
SHIONOGI, INC. via BALLARD PARTNERS
2026 · second_quarter · RR
Advocacy regarding biosecurity issues and treatments for rare disease.
23ANDME RESEARCH INSTITUTE via BALLARD PARTNERS
2026 · second_quarter · RR
Government grants, FDA classification, and NIH genomics policy.
KLAL YISROEL INC. via BALLARD PARTNERS
2026 · first_quarter · 1T
The availability of IVF and reproductive health services.
SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. via BALLARD PARTNERS
2026 · first_quarter · Q1
Medicare coverage and reimbursement for ambulance services.
SIGNATURE PERFORMANCE, INC. via BALLARD PARTNERS
2026 · first_quarter · Q1
Introduce Signature Performance and its capability to assist the VA and DoD in third party collections. With the use of advanced technology and data analytics, the federal government can become more effective in it's revenue collection system.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
SOLUTIONS GROUP SERVICES, LLC via BALLARD PARTNERS
2026 · first_quarter · Q1
Medicare coverage and reimbursement for ambulance services.
OCEANSOUND PARTNERS via BALLARD PARTNERS
2026 · first_quarter · Q1
Work to educate Members and VA Leaders on new technologies in supply chain management.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
MADRIGAL PHARMACEUTICALS, INC. via BALLARD PARTNERS
2026 · first_quarter · Q1
Advocacy related to prescription drug access and pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELFIE MANAGEMENT PTY LTD via BALLARD PARTNERS
2026 · first_quarter · Q1
Rural healthcare access and technology and the VA.
Rural healthcare access and technology and the VA.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA)
GENETIX BIOTHERAPEUTICS INC. via BALLARD PARTNERS
2026 · first_quarter · Q1
Advocacy regarding an FDA issue.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS, INC. via BALLARD PARTNERS
2026 · first_quarter · Q1
Advocacy regarding IVF access and tariffs.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
ARMR SCIENCES INC. via BALLARD PARTNERS
2026 · first_quarter · Q1
Emergency use authorization.
Filing targets: Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), White House Office
AMERIPRO HEALTH LLC via BALLARD PARTNERS
2026 · first_quarter · Q1
Medicare coverage and reimbursement for ambulance services.
2026 · first_quarter · Q1
Civic engagement services for government requirements.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMERIPRO HEALTH LLC via BALLARD PARTNERS
2026 · first_quarter · RR
Medicare coverage and reimbursement for ambulance services.
SOLUTIONS GROUP SERVICES, LLC via BALLARD PARTNERS
2026 · first_quarter · RR
Medicare coverage and reimbursement for ambulance services.
SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. via BALLARD PARTNERS
2026 · first_quarter · RR
Medicare coverage and reimbursement for ambulance services.
HELFIE MANAGEMENT PTY LTD via BALLARD PARTNERS
2026 · first_quarter · RR
Rural healthcare access and technology and the VA.
Rural healthcare access and technology and the VA.
2025 · fourth_quarter · 4A
Civic engagement services for government requirements.
2025 · fourth_quarter · RA
Civic engagement services for government requirements.
UPTODATE, INC. via BALLARD PARTNERS
2025 · fourth_quarter · Q4
Educate Executive Branch and Members of Congress about importance of online medical information to VALNET, VA Library Network.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
RIO BIOPHARMACEUTICALS, INC. via BALLARD PARTNERS
2025 · fourth_quarter · Q4
Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
KLAL YISROEL INC. via BALLARD PARTNERS
2025 · fourth_quarter · Q4
The availability of IVF and reproductive health services.
Filing targets: Executive Office of the President (EOP), White House Office
FERRING PHARMACEUTICALS, INC. via BALLARD PARTNERS
2025 · fourth_quarter · Q4
Advocacy regarding IVF access and tariffs.
Filing targets: Executive Office of the President (EOP), SENATE
2025 · fourth_quarter · Q4
Civic engagement services for government requirements.
2025 · fourth_quarter · RR
Civic engagement services for government requirements.
GENETIX BIOTHERAPEUTICS INC. via BALLARD PARTNERS
2025 · fourth_quarter · RR
Expanded access for genetic treatments for Sickle Cell Disease.
MADRIGAL PHARMACEUTICALS, INC. via BALLARD PARTNERS
2025 · fourth_quarter · RR
Advocacy related to prescription drug access and pricing.
FERRING PHARMACEUTICALS, INC. via BALLARD PARTNERS
2025 · fourth_quarter · RR
Advocacy regarding IVF access and tariffs.
UNIVFY INC. via BALLARD PARTNERS
2025 · third_quarter · Q3
Advocacy and guidance regarding issues pertaining to IVF.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
RIO BIOPHARMACEUTICALS, INC. via BALLARD PARTNERS
2025 · third_quarter · Q3
Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.
Filing targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PUBLIX SUPER MARKETS, INC. via BALLARD PARTNERS
2025 · third_quarter · Q3
Labor and hiring practice issues; compliance with environmental regulations.
Healthcare policy reforms; Healthcare and budget reconciliation.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
PRESCIENT MEDICINE HOLDINGS, INC. via BALLARD PARTNERS
2025 · third_quarter · Q3
Medicare coverage issues.
Filing targets: Health & Human Services, Dept of (HHS)
MERCK SHARP & DOHME LLC via BALLARD PARTNERS
2025 · third_quarter · 3A
Guidance and advocacy related to drug pricing and tariffs.
Guidance and advocacy related to drug pricing and tariffs.
MERCK SHARP & DOHME LLC via BALLARD PARTNERS
2025 · third_quarter · Q3
Guidance and advocacy related to drug pricing and tariffs.
Guidance and advocacy related to drug pricing and tariffs.
KLAL YISROEL INC. via BALLARD PARTNERS
2025 · third_quarter · Q3
The availability of IVF and reproductive health services.
Filing targets: Executive Office of the President (EOP), White House Office
CAN COMMUNITY HEALTH via BALLARD PARTNERS
2025 · third_quarter · Q3
Advocacy and guidance regarding HHS reorganization and grant funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ALKERMES, INC. via BALLARD PARTNERS
2025 · third_quarter · Q3
Provide guidance and advice regarding mental health, public health and regulatory reform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office
PUBLIX SUPER MARKETS, INC. via BALLARD PARTNERS
2025 · second_quarter · 2A
Labor and hiring practice issues; compliance with environmental regulations.
Healthcare policy reforms; Healthcare and budget reconciliation.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
PUBLIX SUPER MARKETS, INC. via BALLARD PARTNERS
2025 · second_quarter · 2A
Labor and hiring practice issues; compliance with environmental regulations.
Healthcare policy reforms; Healthcare and budget reconciliation.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
MERCK SHARP & DOHME LLC via BALLARD PARTNERS
2025 · third_quarter · RR
Guidance and advocacy related to drug pricing and tariffs.
Guidance and advocacy related to drug pricing and tariffs.
PUBLIX SUPER MARKETS, INC. via BALLARD PARTNERS
2025 · second_quarter · Q2
Labor and hiring practice issues; compliance with environmental regulations.
Healthcare policy reforms; Healthcare and budget reconciliation.
Filing targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
UNIVFY INC. via BALLARD PARTNERS
2025 · second_quarter · Q2
Advocacy and guidance regarding issues pertaining to IVF.
Filing targets: Centers For Disease Control & Prevention (CDC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE, White House Office
RIO BIOPHARMACEUTICALS, INC. via BALLARD PARTNERS
2025 · second_quarter · Q2
Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.
Filing targets: Health & Human Services, Dept of (HHS)
PRESCIENT MEDICINE HOLDINGS, INC. via BALLARD PARTNERS
2025 · second_quarter · Q2
Advocate on issues pertaining to medicare coverage.
Filing targets: Health & Human Services, Dept of (HHS)
CAN COMMUNITY HEALTH via BALLARD PARTNERS
2025 · second_quarter · Q2
Advocacy and guidance regarding HHS reorganization and grant funding.
ALKERMES, INC. via BALLARD PARTNERS
2025 · second_quarter · Q2
Provide guidance and advice regarding mental health, public health and regulatory reform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office
RIO BIOPHARMACEUTICALS, INC. via BALLARD PARTNERS
2025 · second_quarter · RR
Assisting with applications before the Food & Drug Administration for generic pharmaceutical approvals.
PUBLIX SUPER MARKETS, INC. via BALLARD PARTNERS
2025 · second_quarter · RR
Labor and hiring practice issues; compliance with environmental regulations; healthcare reforms impacting pharmacies.
Labor and hiring practice issues; compliance with environmental regulations; healthcare reforms impacting pharmacies.
CAN COMMUNITY HEALTH via BALLARD PARTNERS
2025 · second_quarter · RR
Advocacy and guidance regarding HHS reorganization and grant funding.
UNIVFY INC. via BALLARD PARTNERS
2025 · second_quarter · RR
Advocacy and guidance regarding issues pertaining to IVF.
PRESCIENT MEDICINE HOLDINGS, INC. via BALLARD PARTNERS
2025 · first_quarter · Q1
Advocate on issues pertaining to medicare coverage.
Filing targets: Health & Human Services, Dept of (HHS)
ALKERMES, INC. via BALLARD PARTNERS
2025 · first_quarter · Q1
Provide guidance and advice regarding mental health, public health and regulatory reform.
Filing targets: White House Office
PRESCIENT MEDICINE HOLDINGS, INC. via BALLARD PARTNERS
2025 · first_quarter · RR
Advocate on issues pertaining to medicare coverage.
ALKERMES, INC. via BALLARD PARTNERS
2025 · first_quarter · RR
Provide guidance and advice regarding mental health, public health and regulatory reform.